Viracta Therapeutics, Inc.
VIRX
$0.022
$0.005533.33%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -43.29M | -45.34M | -47.99M | -51.06M | -47.62M |
| Total Depreciation and Amortization | 439.00K | 457.00K | 480.00K | 492.00K | 426.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.09M | 5.22M | 5.51M | 5.60M | 6.01M |
| Change in Net Operating Assets | 2.97M | 1.42M | 5.60M | 5.08M | 3.42M |
| Cash from Operations | -34.80M | -38.24M | -36.40M | -39.89M | -37.77M |
| Capital Expenditure | 0.00 | 51.00K | -138.00K | -138.00K | -138.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.33M | 44.21M | 36.68M | 15.14M | 5.66M |
| Cash from Investing | 43.33M | 44.26M | 36.54M | 15.00M | 5.53M |
| Total Debt Issued | -- | -- | -- | -- | 19.99M |
| Total Debt Repaid | -8.60M | -6.68M | -6.68M | -- | -- |
| Issuance of Common Stock | 342.00K | 342.00K | 502.00K | 438.00K | 1.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.26M | -6.34M | -6.18M | 438.00K | 21.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 271.00K | -312.00K | -6.04M | -24.46M | -10.62M |